BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2469277)

  • 1. Alpha-2 antiplasmin in acute nonlymphoblastic leukemia.
    Cofrancesco E; Pogliani E; Salvatore M; Moreo G; Boschetti C; Cortellaro M
    Acta Haematol; 1989; 81(3):122-5. PubMed ID: 2469277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase in the D-dimer levels during treatment in patients with acute myelogenous leukemia.
    Velasco F; Torres A; Rojas R; Alvarez MA; Gomez P; Castillo D
    Haemostasis; 1992; 22(3):117-23. PubMed ID: 1427455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in plasma levels of protease and fibrinolytic inhibitors induced by treatment in acute myeloid leukemia.
    Velasco F; Torres A; Andres P; Martinez F; Gomez P
    Thromb Haemost; 1984 Aug; 52(1):81-4. PubMed ID: 6238445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors and inhibitors of blood coagulation and fibrinolysis in acute nonlymphoblastic leukaemia.
    Bratt G; Blombäck M; Paul C; Schulman S; Törnebohm E; Lockner D
    Scand J Haematol; 1985 Apr; 34(4):332-9. PubMed ID: 3858983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A continuous spectrum of hypercoagulability exists in acute nonlymphoblastic leukemia.
    Sureda A; García Frade LJ; Torrado MC; García Laraña J; García Avello A
    Acta Haematol; 1992; 88(2-3):100-4. PubMed ID: 1281598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Turnover of alpha-2-antiplasmin in patients with acute promyelocytic leukemia.
    Kahle LH; Avvisati G; Lamping RJ; Moretti T; Mandelli F; ten Cate JW
    Scand J Clin Lab Invest Suppl; 1985; 178():75-80. PubMed ID: 2418490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Automation of colorimetry using chromogenic substrates, with special reference to blood coagulation disorders in acute myelocytic leukemia].
    Hashizume K; Tanaki T; Horita H; Yoshitani H; Kumatani Y; Matsuda T; Ito K
    Rinsho Byori; 1985 Feb; Spec No 61():114-8. PubMed ID: 3858561
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased proteolysis of antithrombin III Vicenza during disseminated intravascular coagulation in acute leukemia.
    Castaman G; Ruggeri M; Rodeghiero F
    Thromb Res; 1989 Sep; 55(5):661-4. PubMed ID: 2814948
    [No Abstract]   [Full Text] [Related]  

  • 9. [Analysis of the fibrinolytic response on disseminated intravascular coagulation].
    García Frade LJ; García Avello A
    Sangre (Barc); 1993 Jun; 38(3):221-4. PubMed ID: 7692611
    [No Abstract]   [Full Text] [Related]  

  • 10. Imbalance between thrombin and plasmin activity in disseminated intravascular coagulation. Assessment by the thrombin-antithrombin-III complex/plasmin-alpha-2-antiplasmin complex ratio.
    Kario K; Matsuo T; Kodama K; Matsuo M; Yamamoto K; Kobayashi H
    Haemostasis; 1992; 22(4):179-86. PubMed ID: 1468720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antithrombin III and alpha 2-plasmin inhibitor in DIC--the significance of their levels and existence of complexes as diagnostic indicators].
    Tsuda T; Hayashi H; Tsurumi N; Kuroda M; Takai Y; Kimura I
    Rinsho Ketsueki; 1985 Mar; 26(3):332-40. PubMed ID: 3162051
    [No Abstract]   [Full Text] [Related]  

  • 12. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
    Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
    Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmin-alpha 2-plasmin inhibitor complex in plasma of patients with disseminated intravascular coagulation.
    Takahashi H; Hanano M; Takizawa S; Tatewaki W; Shibata A
    Am J Hematol; 1988 Jul; 28(3):162-6. PubMed ID: 2457307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High plasma urokinase-type plasminogen activator levels are present in patients with acute nonlymphoblastic leukemia.
    García Frade LJ; Sureda A; Torrado MC; García Avello A
    Acta Haematol; 1992; 88(1):7-10. PubMed ID: 1414164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of protein C, protein S, and antithrombin III in acute leukemia.
    Dixit A; Kannan M; Mahapatra M; Choudhry VP; Saxena R
    Am J Hematol; 2006 Mar; 81(3):171-4. PubMed ID: 16493609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical relevance of determination of plasma ATIII and alpha 2 PI activities in patients with DIC--application of the molecular markers for the analysis of pathophysiology of DIC].
    Okajima K
    Rinsho Byori; 1994 Jan; 42(1):45-55. PubMed ID: 8107283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coincidence of acquired factor-X deficiency and disseminated intravascular coagulation in patients with acute nonlymphoblastic leukemia.
    Pabinger I; Bettelheim P; Dudczak R; Hinterberger W; Kyrle PA; Niessner H; Schwarzinger I; Speiser W; Lechner K
    Ann Hematol; 1991 May; 62(5):174-9. PubMed ID: 2049464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Activation of intravascular coagulation and fibrinolysis in cases of APL].
    Asakura H; Saito M; Jokaji H; Uotani C; Kumabashiri I; Matsuda T
    Rinsho Byori; 1989 Apr; Spec No 81():224-8. PubMed ID: 2526885
    [No Abstract]   [Full Text] [Related]  

  • 19. [Blood coagulation changes in children with acute myelogenous leukemia: thrombin effect or proteolysis].
    von Kries R; Ebell W; Jürgens H; Göbel U
    Klin Padiatr; 1984; 196(3):174-7. PubMed ID: 6590923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The proteinase inhibitor complexes (antithrombin III-thrombin, alpha 2antiplasmin-plasmin and alpha 1antitrypsin-elastase) in septicemia, fulminant hepatic failure and cardiac shock: value for diagnosis and therapy control in DIC/F syndrome.
    Egbring R; Seitz R; Blanke H; Leititis J; Kesper HJ; Burghard R; Fuchs G; Lerch L
    Behring Inst Mitt; 1986 Feb; (79):87-103. PubMed ID: 2424425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.